Overexpression of GFAP in Alzheimer's disease, Parkinson's disease, and healthy patients is correlated with myelin impairment (Han et al., 2019), and astrogliosis can inhibit axonal regeneration (Sofroniew & Vinters, 2010). Here, GFAP is linked to Parkinson disease.